DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7e8f38/angioimmunoblastic) has announced the addition of GlobalData's new report "Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011" to their offering.
The Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011 provides in-depth information and data relating to the clinical trials on Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy.
It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope:
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrolment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top companies
- Clinical trial overview of top Universities/Institutes/Hospitals
Reasons to Buy:
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
Key Topics Covered:
- Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Countries Contributing to Clinical Trials in North America
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Clinical Trial Overview of Top Universities/Institutes/Hospitals
For more information visit http://www.researchandmarkets.com/research/7e8f38/angioimmunoblastic